AlphaCentric LifeSci Healthcare Fund Class A (LYFAX) Forecast
See the Price Targets and Ratings of:
LYFAX Analyst Rating
Strong Buy
61ConsensusRatings
51Buy10Hold0Sell
Based on the Wall Street analyst consensus for 61 of LYFAX’s holdings.
LYFAX Analyst Price Target
Average Price Target
$26.06â–²(43.67% Upside)
Based on Wall Street analyst 12-month price targets for 61 of AlphaCentric LifeSci Healthcare Fund Class A’s holdings in the last 3 months. The average price target is $26.06 with a high forecast of $32.17 and a low forecast of $19.30. The average price target represents a 43.67% change from the last price of $18.14.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$32.17
Average$26.06
Low$19.30
Past 12 Months12 Month Forecast$13$18$23$28$33Feb2026May2026Aug2026Nov2026Nov2027
What is LYFAX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 61 of LYFAX’s holdings, AlphaCentric LifeSci Healthcare Fund Class A’s 12-month average price target is $26.06.
What is LYFAX’s upside potential, based on the analysts’ average price target?
LYFAX’s average price target of $26.06 represents a 43.67% upside from its last price of $18.14.
Is LYFAX a Buy, Sell or Hold?
AlphaCentric LifeSci Healthcare Fund Class A has a consensus rating of Strong Buy, based on the analyst consensus for 61 of LYFAX’s holdings: 51 rated Buy, 10 rated Hold and 0 rated Sell.
What is AlphaCentric LifeSci Healthcare Fund Class A’s price target?
The average price target for AlphaCentric LifeSci Healthcare Fund Class A is $26.06, based on Wall Street analyst 12-month price targets for 61 of LYFAX’s holdings, issued in the past 3 months. The highest price target is $32.17 and the lowest is $19.30. The average price target represents a 43.67% increase from the last price of $18.14.
How can I buy shares of LYFAX?
You can buy shares of LYFAX through a brokerage account. Compare brokers on our Best Online Brokers page.